Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Magn Reson Imaging ; 102: 38-42, 2023 10.
Article in English | MEDLINE | ID: mdl-36608910

ABSTRACT

The lenticulostriate artery (LSA) is a vital perforating cerebral artery, whose occlusion often leads to lacunar infarction. Currently, digital subtraction angiography is mainly used to visualize the LSA in the clinical setting; however, its invasiveness is an important limiting factor. Studies have shown that time-of-flight (TOF) sequencing using a high-field magnetic resonance system (7 T) can better image the LSA. However, the diameter of the LSA is extremely small (approximately 0.3-0.7 mm) with relatively slow blood flow velocity; therefore, imaging the LSA with a 3-T magnetic resonance imaging (MRI) scanner remains challenging. This study aimed to visualize the LSA using 3-dimensional-TOF magnetic resonance angiography (MRA) with compressed sensing using a 3-T system and compare the length and number of the LSAs between patients with infarction and normal controls. The scan times of 3D-TOF MRA with and without compressed sensing were 7 min, and 8 min 44 s, respectively. VR displayed the LSA clearly under both conditions. The total number (p > 0.05) and length (p > 0.05) of the LSAs did not differ significantly between 3D-TOF MRA with and without compressed sensing. However, the total length and number of visualized LSAs was significantly lower (p < 0.05) in the infarction group compared to the control group for both TOF MRA and TOF MRA with compressed sensing. TOF MRA combined with compressed sensing is clinically valuable for analyzing the morphological characteristics of the LSA, and shortens the imaging time to 7 min. This combined technique can meet the requirements of shorter scanning times in clinical settings.


Subject(s)
Magnetic Resonance Angiography , Magnetic Resonance Imaging , Humans , Magnetic Resonance Angiography/methods , Magnetic Resonance Imaging/methods , Middle Cerebral Artery , Cerebral Arteries/diagnostic imaging , Infarction , Imaging, Three-Dimensional
2.
Int J Infect Dis ; 92: 208-213, 2020 Mar.
Article in English | MEDLINE | ID: mdl-31978583

ABSTRACT

OBJECTIVE: The risk factors and the impact of NAI treatments in patients with severe influenza A-associated pneumonia remain unclear. METHODS: A multicenter, retrospective, observational study was conducted in Zhejiang, China during a severe influenza epidemic in August 2017-May 2018. Clinical records of patients (>14 y) hospitalized with laboratory-confirmed influenza A virus infection and who developed severe pneumonia were compared to those with mild-to-moderate pneumonia. Risk factors related to pneumonia severity and effects of NAI treatments (monotherapy and combination of peramivir and oseltamivir) were analyzed. RESULTS: 202 patients with influenza A-associated severe pneumonia were enrolled, of whom 84 (41.6%) had died. Male gender (OR = 1.782; 95% CI: 1.089-2.917; P = 0.022), chronic pulmonary disease (OR = 2.581; 95% CI: 1.447-4.603; P = 0.001) and diabetes mellitus (OR = 2.042; 95% CI: 1.135-3.673; P = 0.017) were risk factors related to influenza A pneumonia severity. In cox proportional hazards model, severe pneumonia patients treated with double dose oseltamivir (300mg/d) had a better survival rate compared to those receiving a single dose (150 mg/d) (HR = 0.475; 95%CI: 0.254-0.887; P = 0.019). However, different doses of peramivir (300 mg/d vs. 600 mg/d) and combination therapy (oseltamivir-peramivir vs. monotherapy) showed no differences in 60-day mortality (P = 0.392 and P = 0.658, respectively). CONCLUSIONS: Patients with male gender, chronic pulmonary disease, or diabetes mellitus were at high risk of developing severe pneumonia after influenza A infection. Double dose oseltamivir might be considered in treating influenza A-associated severe pneumonia.


Subject(s)
Antiviral Agents/therapeutic use , Influenza A virus/physiology , Influenza, Human/complications , Influenza, Human/epidemiology , Neuraminidase/antagonists & inhibitors , Oseltamivir/therapeutic use , Pneumonia, Viral/epidemiology , Acids, Carbocyclic , China , Cyclopentanes/therapeutic use , Epidemics , Female , Guanidines/therapeutic use , Humans , Influenza, Human/drug therapy , Influenza, Human/virology , Male , Middle Aged , Pneumonia, Viral/drug therapy , Proportional Hazards Models , Retrospective Studies , Risk Factors
3.
J Craniofac Surg ; 29(3): e261-e262, 2018 May.
Article in English | MEDLINE | ID: mdl-29381635

ABSTRACT

Traditionally, lacerations of bridging vessels were surmised to cause chronic subdural hematoma (CSDH), although neither observation studies nor medical research was able to testify this. Nowadays, an inflammatory process is known to take place in the development of CSDH. Of note, post-traumatic angiogenesis at its early stage also features inflammation with immune cell infiltration. The authors found a patient suffering from CSDH with unusual angiogenesis between dura and pia matters. The observation of dura-and-pia angiogenesis may be a piece of evidence to underline compensatory reaction of central nervous system to offset the negative effects produced by CSDH, and points out to a possible approach of bolstering angiogenesis to manage ischemic diseases in cerebral hemispheres.


Subject(s)
Hematoma, Subdural, Chronic , Neovascularization, Pathologic , Aged , Female , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...